RPID
Income statement / Annual
Last year (2024), Rapid Micro Biosystems, Inc.'s total revenue was $28.05 M,
an increase of 24.57% from the previous year.
In 2024, Rapid Micro Biosystems, Inc.'s net income was -$46.89 M.
See Rapid Micro Biosystems, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$28.05 M |
$22.52 M |
$17.13 M |
$23.23 M |
$16.08 M |
$16.51 M |
| Cost of Revenue |
$28.16 M
|
$28.00 M
|
$25.67 M
|
$30.97 M
|
$24.15 M
|
$16.75 M
|
| Gross Profit |
-$109.00 K
|
-$5.49 M
|
-$8.54 M
|
-$7.74 M
|
-$8.07 M
|
-$234.00 K
|
| Gross Profit Ratio |
-0
|
-0.24
|
-0.5
|
-0.33
|
-0.5
|
-0.01
|
| Research and Development Expenses |
$14.60 M
|
$12.82 M
|
$12.87 M
|
$9.78 M
|
$6.53 M
|
$5.43 M
|
| General & Administrative Expenses |
$21.95 M
|
$24.94 M
|
$26.82 M
|
$17.90 M
|
$9.98 M
|
$8.92 M
|
| Selling & Marketing Expenses |
$13.27 M
|
$13.32 M
|
$14.99 M
|
$11.82 M
|
$5.96 M
|
$4.05 M
|
| Selling, General & Administrative Expenses |
$35.21 M
|
$38.26 M
|
$41.81 M
|
$29.71 M
|
$15.94 M
|
$12.97 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$49.81 M
|
$51.08 M
|
$54.68 M
|
$39.49 M
|
$22.47 M
|
$18.40 M
|
| Cost And Expenses |
$77.97 M
|
$79.08 M
|
$80.35 M
|
$70.46 M
|
$46.62 M
|
$35.15 M
|
| Interest Income |
$3.16 M
|
$4.21 M
|
$1.78 M
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$2.65 M
|
$3.45 M
|
$2.38 M
|
| Depreciation & Amortization |
$3.36 M
|
$3.11 M
|
$2.84 M
|
$1.53 M
|
$1.50 M
|
$1.50 M
|
| EBITDA |
-$46.56 M |
-$53.46 M |
-$60.38 M |
-$45.70 M |
-$32.00 M |
-$16.87 M |
| EBITDA Ratio |
-1.66
|
-2.37
|
-3.52
|
-1.97
|
-1.99
|
-1.02
|
| Operating Income Ratio |
-1.78
|
-2.51
|
-3.69
|
-2.03
|
-1.9
|
-1.13
|
| Total Other Income/Expenses Net |
$3.05 M
|
$4.13 M
|
$1.84 M
|
-$26.20 M
|
-$6.40 M
|
-$2.11 M
|
| Income Before Tax |
-$46.87 M
|
-$52.44 M
|
-$61.38 M
|
-$73.43 M
|
-$36.94 M
|
-$20.74 M
|
| Income Before Tax Ratio |
-1.67
|
-2.33
|
-3.58
|
-3.16
|
-2.3
|
-1.26
|
| Income Tax Expense |
$22.00 K
|
$31.00 K
|
-$576.00 K
|
$91.00 K
|
$134.00 K
|
$427.00 K
|
| Net Income |
-$46.89 M
|
-$52.47 M
|
-$60.81 M
|
-$73.52 M
|
-$37.08 M
|
-$21.17 M
|
| Net Income Ratio |
-1.67
|
-2.33
|
-3.55
|
-3.16
|
-2.31
|
-1.28
|
| EPS |
-1.08 |
-1.22 |
-1.43 |
-1.88 |
-1.17 |
-0.53 |
| EPS Diluted |
-1.08 |
-1.22 |
-1.43 |
-1.88 |
-1.17 |
-0.53 |
| Weighted Average Shares Out |
$43.58 M
|
$43.02 M
|
$42.45 M
|
$41.47 M
|
$38.67 M
|
$39.66 M
|
| Weighted Average Shares Out Diluted |
$43.58 M
|
$43.02 M
|
$42.45 M
|
$41.47 M
|
$38.67 M
|
$39.66 M
|
| Link |
|
|
|
|
|
|
